ArticleOne health (Amsterdam, Netherlands)2025
Guidelines for addressing disease risks in wildlife trade.
Article in One health (Amsterdam, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systematic review of health risk assessment in Africa's bushmeat trade: Are there any risks assessed?PLoS neglected tropical diseases · 2026Pooled it
- Herpes B virus and the neglected risk of zoonotic spillover.One health (Amsterdam, Netherlands) · 2026Review
- Applying one health approaches to addressing disease risks in wildlife trade: Insights from a special issue.One health (Amsterdam, Netherlands) · 2026Article
- Demographic skew and market dynamics reveal unsustainable trade and conservation risks of the West African dwarf crocodile.Scientific reports · 2026Article
- The Role of Foxes in Transmitting Zoonotic Bacteria to Humans: A Scoping Review.Zoonoses and public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wildlife trade for commercial and subsistence purposes has a long history and economic, cultural and religious value, but also presents potential trade-offs, including for human and animal (domestic and wild) health, animal welfare, species conservation, and ecosystems. Understanding and balancing the many dimensions of trade requires a holistic approach. To assist in decision making, the World Organisation for Animal Health (WOAH) undertook a process to develop draft guidelines, convening a multi-sectoral ad hoc group, reinforced with expertise from a WOAH Collaborating Centre and a peer review process. The draft guidelines were piloted through a workshop series in Bangkok, Thailand, informing their refinement and finalization. The Guidelines for Addressing Disease Risks in Wildlife Trade, published in May 2024, present a high-level framework to assess risk and identify risk-management strategies for wildlife trade. The Guidelines are structured by four main sections, stakeholder engagement and system mapping; risk analysis (the stages of hazard identification, risk assessment, risk management, and risk communication); monitoring and evaluation; and tools and guidance. Rather than being prescriptive, the Guidelines can be a basis for advancing context-specific approaches to addressing disease risk in the wildlife trade using a One Health lens, supported by workshops and multi-sectoral collaboration to strengthen risk analysis competencies and implementation. This paper describes the process of developing the Guidelines and summarizes their content and anticipated use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.